SuperworthCandel Therapeutics shares outstanding CADL
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 74.1M
- On a year earlier
- +44.0%
- more shares
Candel Therapeutics had 74.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 44.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 54.9M | +54% |
| FY2024 | 35.6M | +23% |
| FY2023 | 29M | +0% |
| FY2022 | 28.9M | +1% |
| FY2021 | 28.6M | +147% |
| FY2020 | 11.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 74.1M | +44% | |
| Q1 FY26 | 62.4M | +14% | |
| Q4 FY25 | 54.9M | +54% | |
| Q3 FY25 | 54.9M | +71% | |
| Q2 FY25 | 51.5M | +72% | |
| Q1 FY25 | 54.8M | +88% | |
| Q4 FY24 | 35.6M | +23% | |
| Q3 FY24 | 32M | +11% | |
| Q2 FY24 | 29.9M | +3% | |
| Q1 FY24 | 29.2M | +1% | |
| Q4 FY23 | 29M | +0% | |
| Q3 FY23 | 28.9M | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Candel Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.